BetterWealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$757K Hold
654
– – 0.13% 37
2026
Q2
$784K Buy
654
+2
+0.3% +$2.04K 0.14% 40
2026
Q1
$600K Buy
652
+68
+12% +$68.9K 0.12% 40
2025
Q4
$627K Sell
584
-8
-1% -$7.65K 0.14% 36
2025
Q3
$452K Buy
592
+14
+2% +$10.4K 0.11% 40
2025
Q2
$450K Hold
578
– – 0.12% 37
2025
Q1
$477K Sell
578
-11
-2% -$9.15K 0.13% 34
2024
Q4
$455K Buy
589
+21
+4% +$17.4K 0.13% 38
2024
Q3
$503K Hold
568
– – 0.15% 35
2024
Q2
$514K Hold
568
– – 0.16% 33
2024
Q1
$442K Sell
568
-6
-1% -$4.27K 0.14% 39
2023
Q4
$334K Buy
574
+6
+1% +$3.5K 0.11% 47
2023
Q3
$305K Hold
568
– – 0.12% 37
2023
Q2
$266K Buy
+568
New +$238K 0.1% 37
2023
Q1
– Sell
-568
Closed -$208K – 45
2022
Q4
$208K Buy
+568
New +$201K 0.09% 38

Other funds holding LLY

BetterWealth's LLY Position: Q3 2026 in Review

BetterWealth held its Eli Lilly (LLY) position steady in Q3 2026 at 654 shares worth $757K. The position accounts for 0.13% of the portfolio, ranked #37.

BetterWealth first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $784K in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • BetterWealth held 654 shares of Eli Lilly worth $757K as of Q3 2026.
  • BetterWealth left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.13% of BetterWealth's portfolio in Q3 2026, its #37 holding.
  • BetterWealth first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • BetterWealth's Eli Lilly position peaked at $784K in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on BetterWealth's 13F filing for Q3 2026, filed 15 Oct 2026.